Chargement en cours...

Harnessing the Natural Biology of Adeno-Associated Virus to Enhance the Efficacy of Cancer Gene Therapy

Adeno-associated virus (AAV) was first characterized as small “defective” contaminant particles in a simian adenovirus preparation in 1965. Since then, a recombinant platform of AAV (rAAV) has become one of the leading candidates for gene therapy applications resulting in two FDA-approved treatments...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Viruses
Auteurs principaux: Bower, Jacquelyn J., Song, Liujiang, Bastola, Prabhakar, Hirsch, Matthew L.
Format: Artigo
Langue:Inglês
Publié: MDPI 2021
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8309980/
https://ncbi.nlm.nih.gov/pubmed/34201599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13071205
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!